Studies related to Sleep Quality and Fish Oil

Influence Of Adjuvant Omega-3-polyunsaturated Fatty Acids On Depression, Sleep, And Emotion Regulation Among Outpatients With Major Depressive Disorders - Results From A Double-blind, Randomized And Placebo-controlled Clinical Trial

Effect Decrease
Values ISI. Mean and SD. Placebo: before 17.60 (4.76) , after 10.36 (2.56). Omega-3: before 20.32 (4.22), after 3.48 (1.26).
Trial Design Randomized trial
Trial Length 1-6 months
Number of Subjects 50
Sex Both Genders
Age Range 18-29, 30-44, 45-64, 65+
Notes for this study:
In a randomized, double-blind, placebo-controlled trial, 50 participants with major depressive disorders were allocated to take 1000 mg of omega-3 fatty acids or placebo daily for 12 weeks.

There was a statistically significantly greater improvement in both measures of depression, insomnia, and anxiety, in the omega-3 group as compared with the placebo group.

Full details on all 3 studies are available to Examine Members. Try out the Examine Membership with a 14-day free trial.

Already a Member? Log in now to access.